Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 25 November 2021

Hungarian is available via eTranslation, the European Commission's machine translation service.

Translate to Hungarian | Important information about machine translation

Date

csütörtök, 25 november 2021, Egész nap

Helyszín

Online
European Medicines Agency, Amsterdam, the Netherlands

This extraordinary meeting is organised to discuss the evaluation of an application to extend the use of Comirnaty, a vaccine for COVID-19 developed by BioNTech and Pfizer, to include children aged 5 to 11.

EMA will communicate on the outcome of the meeting. 

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.

Share this page